297 related articles for article (PubMed ID: 9566856)
1. Body fat distribution, insulin mediated suppression of non-esterified fatty acids and plasma triglycerides in obese subjects.
Herranz L; Zapata A; Grande C; Megia A; Pallardo LF
Horm Metab Res; 1998 Mar; 30(3):141-5. PubMed ID: 9566856
[TBL] [Abstract][Full Text] [Related]
2. Insulin sensitivity indices of glucose and free fatty acid metabolism in obese children and adolescents in relation to serum lipids.
Reinehr T; Kiess W; Andler W
Metabolism; 2005 Mar; 54(3):397-402. PubMed ID: 15736120
[TBL] [Abstract][Full Text] [Related]
3. Fasting serum free fatty acid composition, waist/hip ratio and insulin activity in essential hypertensive patients.
Wang S; Ma A; Song S; Quan Q; Zhao X; Zheng X
Hypertens Res; 2008 Apr; 31(4):623-32. PubMed ID: 18633173
[TBL] [Abstract][Full Text] [Related]
4. Microcirculatory damage of common carotid artery wall in obese and non obese subjects.
Ciccone M; Maiorano A; De Pergola G; Minenna A; Giorgino R; Rizzon P
Clin Hemorheol Microcirc; 1999; 21(3-4):365-74. PubMed ID: 10711772
[TBL] [Abstract][Full Text] [Related]
5. Plasma adiponectin levels in overweight and obese Asians.
Yang WS; Lee WJ; Funahashi T; Tanaka S; Matsuzawa Y; Chao CL; Chen CL; Tai TY; Chuang LM
Obes Res; 2002 Nov; 10(11):1104-10. PubMed ID: 12429873
[TBL] [Abstract][Full Text] [Related]
6. Effect of glucose tolerance status on PAI-1 plasma levels in overweight and obese subjects.
Pannacciulli N; De Mitrio V; Marino R; Giorgino R; De Pergola G
Obes Res; 2002 Aug; 10(8):717-25. PubMed ID: 12181379
[TBL] [Abstract][Full Text] [Related]
7. Effect of obesity on susceptibility to fatty acid-induced peripheral tissue insulin resistance.
Kruszynska YT; Olefsky JM; Frias JP
Metabolism; 2003 Feb; 52(2):233-8. PubMed ID: 12601639
[TBL] [Abstract][Full Text] [Related]
8. Urinary albumin excretion in lean, overweight and obese glucose tolerant individuals: its relationship with dyslipidaemia, hyperinsulinaemia and blood pressure.
Hoffmann IS; Jimenez E; Cubeddu LX
J Hum Hypertens; 2001 Jun; 15(6):407-12. PubMed ID: 11439316
[TBL] [Abstract][Full Text] [Related]
9. Is an exaggerated postprandial triglyceride response associated with the component features of the insulin resistance syndrome?
Byrne CD; Wareham NJ; Phillips DI; Hales CN; Martensz ND
Diabet Med; 1997 Nov; 14(11):942-50. PubMed ID: 9400918
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of metformin in normoglycemic morbidly obese adolescents.
Kay JP; Alemzadeh R; Langley G; D'Angelo L; Smith P; Holshouser S
Metabolism; 2001 Dec; 50(12):1457-61. PubMed ID: 11735093
[TBL] [Abstract][Full Text] [Related]
11. Pattern of obesity and insulin, glucagon, sex hormone binding globulin and lipids in obese Arab women.
Emara MK; Saadah A; Hassan M; Moussa M; Hourani H
Diabetes Res; 1989 Apr; 10(4):175-81. PubMed ID: 2692944
[TBL] [Abstract][Full Text] [Related]
12. Insulin response and changes in composition of non-esterified fatty acids in blood plasma of middle-aged men following isoenergetic fatty and carbohydrate breakfasts.
Frape DL; Williams NR; Carpenter KL; Freeman MA; Palmer CR; Fletcher RJ
Br J Nutr; 2000 Nov; 84(5):737-45. PubMed ID: 11177189
[TBL] [Abstract][Full Text] [Related]
13. Basal intermediary metabolism in impaired glucose tolerance and morbid obesity.
Krentz AJ; Singh BM; Hale PJ; Robertson DA; Nattrass M
Diabetes Res; 1992; 20(3):51-60. PubMed ID: 1345002
[TBL] [Abstract][Full Text] [Related]
14. Fasting nonesterified fatty acid profiles in childhood and their relationship with adiposity, insulin sensitivity, and lipid levels.
Sabin MA; De Hora M; Holly JM; Hunt LP; Ford AL; Williams SR; Baker JS; Retallick CJ; Crowne EC; Shield JP
Pediatrics; 2007 Dec; 120(6):e1426-33. PubMed ID: 18055661
[TBL] [Abstract][Full Text] [Related]
15. Effects of oral L-carnitine supplementation on insulin sensitivity indices in response to glucose feeding in lean and overweight/obese males.
Galloway SD; Craig TP; Cleland SJ
Amino Acids; 2011 Jul; 41(2):507-15. PubMed ID: 20963457
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor alpha -238G>A genotype alters postprandial plasma levels of free fatty acids in obese individuals with type 2 diabetes mellitus.
Fontaine-Bisson B; Wolever TM; Chiasson JL; Rabasa-Lhoret R; Maheux P; Josse RG; Leiter LA; Rodger NW; Ryan EA; El-Sohemy A
Metabolism; 2007 May; 56(5):649-55. PubMed ID: 17445540
[TBL] [Abstract][Full Text] [Related]
17. Impact of obesity in primary hyperlipidemias.
Carmena R; Ascaso JF; Real JT
Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):354-9. PubMed ID: 11887432
[TBL] [Abstract][Full Text] [Related]
18. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
Holte J; Bergh T; Berne C; Lithell H
Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels of soluble tumor necrosis factor-alpha receptors are related to total and LDL-cholesterol in lean, but not in obese subjects.
Straczkowski M; Kowalska I; Nikolajuk A; Adamska A; Karolczuk-Zarachowicz M; Karczewska-Kupczewska M; Kozlowska A; Gorska M
Cardiovasc Diabetol; 2006 Jun; 5():14. PubMed ID: 16803616
[TBL] [Abstract][Full Text] [Related]
20. Effect of obesity on circulating intermediary metabolite concentrations in the absence of impaired glucose tolerance.
Robertson DA; Singh BM; Nattrass M
Int J Obes; 1991 Oct; 15(10):635-45. PubMed ID: 1752724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
